Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

By this date it was agreed that a decision whether and when to implement a screening test for Hepatitis C would be made on a UK-wide basis.

Published on: 22 July, 2024

It was agreed at a meeting of the ACVSB to support the general introduction of the test for Hepatitis C if the FDA approved it and the pilot showed it to be "feasible and non-problematic".

Published on: 22 July, 2024

The FDA granted a permit for the Chiron/Ortho test (Hepatitis C test) to be exported for diagnostic use as well as research.

Published on: 22 July, 2024

The ACVSB decided that Hepatitis C testing should not be introduced in advance of a decision by the FDA.

Published on: 22 July, 2024

The ACVSB decided the introduction of routine Hepatitis C screening was not yet justified.

Published on: 22 July, 2024

The FDA approved the anti-HCV ELISA test and US blood banks commenced screening.

Published on: 22 July, 2024

The ACVSB approved Hepatitis C screening in principle but recommended there should be a pilot study to decide which test (Ortho or Abbott) was better.

Published on: 22 July, 2024

The ACVSB agreed Hepatitis C screening should be started as soon as practicable but no date was proposed.

Published on: 22 July, 2024

Minister approved routine screening for Hepatitis C.

Published on: 22 July, 2024

Dr Harold Gunson informed RTC directors that screening for anti-HCV would begin on 1 July 1991.

Published on: 22 July, 2024

The introduction of screening for anti-HCV was postponed to 1 September 1991.

Published on: 22 July, 2024

The Archer Inquiry published its report.

Published on: 22 July, 2024

The Penrose Inquiry published its report.

Published on: 22 July, 2024

Prime Minister Theresa May rejected further calls for an inquiry.

Published on: 22 July, 2024

Andy Burnham called for a public inquiry.

Published on: 22 July, 2024

Six opposition party leaders wrote to the Prime Minister calling for an inquiry.

Published on: 22 July, 2024

Diana Johnson MP secured an emergency debate on a public inquiry.

Published on: 22 July, 2024

The Prime Minister announced the Infected Blood Inquiry.

Published on: 22 July, 2024

Wilson Report was published and led to a new NHS complaints process in 1996.

Published on: 22 July, 2024

Public Law Project evaluation of the new NHS complaints processed.

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2068
  • Page 2069
  • Page 2070
  • Page 2071
  • Current page 2072
  • Page 2073
  • Page 2074
  • Page 2075
  • Page 2076
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.